The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles

Virology

Volumn 318, Issue 2, 2004, Pages 534-541

  Chen, Szu Wen ^a,b   Chiu, Hsu Chen ^a,b   Liao, Wei Hao ^a,b   Wang, Fu Der ^b   Chen, Steve S L ^c   Wang, Chin Tien ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Autoprocessing; Gag Pol; HIV PR

Indexed keywords

GAG PROTEIN; PROTEINASE; VIRUS DNA;

ARTICLE; AUTOCLAVE; CHIMERA; CONTROLLED STUDY; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1242328733     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.08.043     Document Type: Article

References (36)

1. Arrigo S.J., Huffman K. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers. J. Virol. 69:1995;5988-5994.
2. Bennett R., Nelle T.D., Wills J.W. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:1993;6487-6498.
3. Burstein H., Bizub D., Skalka A.M. Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J. Virol. 64:1991;6156-6172.
4. gag-pol into virus particles. J. Virol. 76:2002;3221-3231.
5. Erickson-Viitanen S., Manfredi J., Viitanen P., Tribe D.E., Tritch R., Hutchison C.A. III, Loeb D.D., Swanstrom R. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res. Hum. Retrovir. 5:1989;577-591.
6. Freed E.O. HIV Gag proteins: diverse functions in the virus life cycle. Virology. 251:1998;1-15.
7. Gottlinger H.G., Sodroski J.G., Haseltine W.A. Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5781-5785.
8. Henderson L.E., Bowers M.A., Sowder R.C. II, Serabyn S.A., Johnson D.G., Bess J.W. Jr., Arthur L.O., Bryant D.K., Fenselau C. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processing, and complete amino acid sequences. J. Virol. 66:1992;1856-1865.
9. Hill M.K., Hooker C.W., Harrich D., Crowe S.M., Mak J. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1. J. Virol. 75:2001;6835-6840.
10. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:1994;71-83.
11. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (London). 331:1988;280-283.
12. Kaplan A.H., Manchester M., Swanstorm M. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68:1994;6782-6786.
13. Kohl N.E., Emini E.A., Schleif W.E., Davis L.J., Heimbach J.C., Dixon R.A.F., Scolnick E.M., Sigal I.S. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4686-4890.
14. Krausslich H.-G. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3213-3217.
15. Krausslich H.-G., Ingraham R.H., Skoog M.T., Wimmer E., Pallai P.V., Carter C.A. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc. Natl. Acad. Sci. U.S.A. 86:1989;807-811.
16. Leis J., Baltimore D., Bishop J.B., Coffin J., Fleissner E., Goff S.P., Oroszlan S., Robinson R., Skalka A.M., Temin H.M., Vogt V. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62:1988;1808-1809.
17. Mervis R.J., Ahmad N., Lillehoj E.P., Raum M.G., Salazar F.H.R., Chan H.W., Venkatesan V. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslation modifications, and evidence for alternative gag precursors. J. Virol. 62:1988;3993-4002.
18. Page K.A., Landau N.R., Littman D.R. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:1990;5270-5276.
19. Park J., Morrow C.D. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65:1991;5111-5117.
20. Partin K., Krausslich H.G., Ehrlich L., Wimmer E., Carter C. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J. Virol. 64:1990;3938-3947.
21. Partin K., Zybarth G., Ehrlich L., DeCrombrugghe M., Wimmer E., Carter C. Deletion of sequences upstream of the proteinase improve the proteolytic processing of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4776-4780.
22. Peng C., Ho B.K., Chang T.W., Chang N.T. Role of human immunodeficiency virus type 1-specific protease in core particle maturation and viral infectivity. J. Virol. 63:1989;2550-2556.
23. Pettit S.C., Gulnik S., Everitt L., Kaplan A.H. The dimmer interfaces of protease and extra-protease domains influence the activation of protease and the stability of Gag-Pol cleavage. J. Virol. 77:2003;366-374.
24. Quillent C., Borman A.M., Paulous S., Dauguet C., Clavel F. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology. 219:1996;29-36.
25. Rose J.R., Base L.M., Craik C.S. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 69:1995;2751-2758.
26. Shehu-Xhilaga M., Crowe S.M., Mak J. Maintenance of the Gag/Gag-Pol ration is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75:2001;1834-1841.
27. Tessmer U., Krausslich H.-K. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity. J. Virol. 72:1998;3459-3463.
28. Wang C.-T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:1993;4264-4273.
29. Wang C.-T., Lai H.-Y., Li J.-J. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J. Virol. 72:1998;7950-7959.
30. Wang C.-T., Chou Y.-C., Chiang C.-C. Assembly and processing of human immunodeficiency virus gag mutants containing a partial replacement of the matrix domain by the viral protease domain. J. Virol. 74:2000;3418-3422.
31. Weldon R.A., Wills J.W. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 67:1993;5550-5561.
32. Wills J.W., Craven R.C. Form, function, and use of retroviral gag proteins. AIDS. 5:1991;639-654.
33. Xiang Y., Ridky T.W., Krishna N.K., Leis J. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation. J. Virol. 71:1997;2083-2091.
34. Zhang Y., Qian H., Love Z., Barklis E. Analysis of the assembly functions of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J. Virol. 72:1998;1782-1789.
35. Zybarth G., Carter C. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69:1995;3878-3884.
36. Zybarth G., Krausslich H.G., Partin K., Carter C. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68:1994;240-250.